Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.
Publication
, Journal Article
Mont, MA; Ulrich, SD; Seyler, TM
Published in: J Rheumatol
March 2007
Duke Scholars
Published In
J Rheumatol
ISSN
0315-162X
Publication Date
March 2007
Volume
34
Issue
3
Start / End Page
466 / 468
Location
Canada
Related Subject Headings
- Thrombophilia
- Risk Factors
- Osteonecrosis
- Humans
- Fibrinolysis
- Arthritis & Rheumatology
- Apoprotein(a)
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Mont, M. A., Ulrich, S. D., & Seyler, T. M. (2007). Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol, 34(3), 466–468.
Mont, Michael A., Slif D. Ulrich, and Thorsten M. Seyler. “Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.” J Rheumatol 34, no. 3 (March 2007): 466–68.
Mont MA, Ulrich SD, Seyler TM. Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol. 2007 Mar;34(3):466–8.
Mont, Michael A., et al. “Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis.” J Rheumatol, vol. 34, no. 3, Mar. 2007, pp. 466–68.
Mont MA, Ulrich SD, Seyler TM. Role of thrombotic and fibrinolytic alterations in the pathogenesis and treatment of osteonecrosis. J Rheumatol. 2007 Mar;34(3):466–468.
Published In
J Rheumatol
ISSN
0315-162X
Publication Date
March 2007
Volume
34
Issue
3
Start / End Page
466 / 468
Location
Canada
Related Subject Headings
- Thrombophilia
- Risk Factors
- Osteonecrosis
- Humans
- Fibrinolysis
- Arthritis & Rheumatology
- Apoprotein(a)
- 3204 Immunology
- 3202 Clinical sciences
- 1117 Public Health and Health Services